Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease risk: current status and treatments
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference63 articles.
1. Triglycerides and ASCVD risk reduction: recent insights and future directions;Hussain;Curr Atheroscler Rep,2020
2. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women;Nordestgaard;JAMA,2007
3. New recommendations and revised concepts in recent guidelines on the management of dyslipidemias to prevent cardiovascular disease: the 2018 ACC/AHA and 2019 ESC/EAS guidelines;Raygor;Curr Cardiol Rep,2020
4. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up;Langsted;J Intern Med,2011
5. Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state;White;Clin Chem,2015
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Endothelial Dysfunction in Type 2 Diabetes with an Update on New Interventions;Contemporary Diabetes;2023
2. Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia;International Journal of Molecular Sciences;2022-12-21
3. Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis;Frontiers in Molecular Biosciences;2022-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3